NTLA · Intellia Therapeutics, Inc. · Proposed Sales
$12.26
+0.14 (+1.16%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.65B
Shares
140.13M
Volume · Oct 2
4.5M
Avg daily vol (3M)
3.99M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-20 | LEONARD JOHN M | Officer, Director | 22,675 | 2026-08-20 | UBS Financial Services, Inc. |
| 2026-07-02 | EDWARD DULAC | Officer | 4,677 | 2026-07-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | LEONARD JOHN M | Officer, Director | 88,146 | 2025-12-11 | UBS Financial Services, Inc. |
| 2024-01-08 | Sepp-Lorenzino Laura | Officer | 2,275 | 2024-01-08 | UBS Financial Services, Inc. |
| 2023-12-07 | John F. Crowley | Former Director | 32,791 | 2023-12-06 | E*Trade Financial Corporation |
| 2023-07-31 | MUNA BHANJI | Director | 265 | 2023-07-31 | E*TRADE FINANCIAL CORPORATION |
| 2023-07-06 | MUNA BHANJI | Director | 1,867 | 2023-07-06 | E*TRADE FINANCIAL CORPORATION |
| 2023-06-20 | ELIANA CLARK | Officer | 5,000 | 2023-06-20 | E*TRADE FINANCIAL CORPORATION |
Showing 1–8 of 8 filings
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
11 filings
7 filers
Visit website
Investor relations